Priothera
  • Home
  • Science
    • Mocravimod
    • Acute Myeloid Leukemia & Hematopoietic Cell Transplantation
    • CAR T Cells
    • Our Pipeline
    • Publications
  • MO-TRANS
  • Press
  • About
    • Our Leadership Team
    • Advisory Board
    • Investors
    • Our Partners
    • ESG and Recognition
  • Contact
Select Page

GvHD prophylaxis with KRP203, a sphingosine-1-phosphate receptor modulator, is safe and may have the potential to improve survival in patients undergoing allogeneic stem cell transplantation

by admin | Mar 4, 2019 | Exploring Mocravimod Key Research Highlights

https://priothera.com/gvhd-prophylaxis-with-krp203-a-sphingosine-1-phosphate-receptor-modulator-is-safe-and-may-have-the-potential-to-improve-survival-in-patients-undergoing-allogeneic-stem-cell-transplantation/

Priothera, Adding Quality Years to Life

Get In Touch

Priothera SAS
57 Avenue Général de Gaulle
68300 Saint-Louis, France

Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland

© Priothera Ltd. 2025

Priothera SAS
57 Avenue Général de Gaulle
68300 Saint-Louis, France

Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland